CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- 4 Grant or award Chief Financial Officer acquired 46,781 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 274,000 shares at $28.43 ($7,790,943)
- 4 Open-market sale See Remarks sold 2,490 shares at $28.10 ($69,979)
- 4 Open-market sale See Remarks sold 10,000 shares at $29.85 ($298,450)
- 4 Open-market sale General Counsel sold 4,100 shares at $29.33 ($120,257)
- 4 Open-market sale General Counsel sold 3,576 shares at $29.84 ($106,701)
- 4 Open-market sale See Remarks sold 7,132 shares at $29.84 ($212,805)
- 4 Open-market sale See Remarks sold 3,238 shares at $29.84 ($96,615)
- 4 Grant or award Chief Medical Officer acquired 11,096 shares (grant or award)
- 4 Open-market sale CEO sold 20,272 shares at $29.84 ($604,876)
- 4 Option exercise CEO acquired 46,828 shares (option exercise)
- 4 Option exercise See Remarks acquired 26,189 shares (option exercise)
- 4 Option exercise General Counsel acquired 9,712 shares (option exercise)
- 4 Option exercise See Remarks acquired 6,274 shares (option exercise)
- 4 Open-market sale See Remarks sold 638 shares at $27.20 ($17,356)
- 4 Option exercise See Remarks acquired 1,586 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 20,000 shares at $22.53 ($450,646)
Page 8 of 21 · 406 filings